F052 Behind the Bra: What Dermatologist Should Know about Diseases of the Breast
DESCRIPTION
Skin disease of the breast, including inflammatory, infectious and neoplastic entities, affects many of our patients. Idiopathic granulomatous mastitis will be reviewed including the clinical presentation, occasional co-morbidities, and treatment. We will teach how to evaluate a lactating patient with nipple pain from dermatitis or infection or Raynauds. Breast cancer and the effects of radiation on the breast, including delayed effects, will be discussed. Recognition of dermatologic issues arising from procedures performed in our transgender/gender non- binary patients will be highlighted.
LEARNING OBJECTIVES
Identify and treat inflammatory diseases of the breast such as idiopathic granulomatous mastitis.
Determine causes of pain in the breast during lactation including infectious etiologies.
Identify changes in the breast associated with treatment for breast cancer.
SCHEDULE
1:00 PM
introduction
Miriam Keltz Pomeranz, MD, FAAD
1:05 PM
inflammatory disease of the breast
Miriam Keltz Pomeranz, MD, FAAD
1:20 PM
questions and answers
Miriam Keltz Pomeranz, MD, FAAD
1:25 PM
The breast in pregnancy and lactation
S. Honor Fullerton Stone, MD, FAAD
1:40 PM
questions and answers
S. Honor Fullerton Stone, MD, FAAD
1:45 PM
Malignancies of the Breast
Alina Markova, MD, FAAD
2:00 PM
questions and answers
Alina Markova, MD, FAAD
2:05 PM
Adverse effects of breast cancer treatment
Beth McLellan, MD, FAAD
2:20 PM
questions and answers
Beth McLellan, MD, FAAD
2:25 PM
Concerns with breasts in transgender patients
Matthew David Mansh, MD, FAAD
2:40 PM
questions and answers
Matthew David Mansh, MD, FAAD
2:45 PM
Panel questions and answers
DIRECTOR
Miriam Keltz Pomeranz, MD, FAAD
SPEAKERS
S. Honor Fullerton Stone, MD, FAAD
Matthew David Mansh, MD, FAAD
Alina Markova, MD, FAAD
Beth McLellan, MD, FAAD
HANDOUTS
DISCLOSURES
S. Honor Fullerton Stone, MD, FAAD
No financial relationships exist with ineligible companies.
Matthew David Mansh, MD, FAAD
No financial relationships exist with ineligible companies.
Alina Markova, MD, FAAD
ADC Therapeutics – Consultant(Fees); Alira Health Ventures – Consultant(Honoraria); Amryt Pharma – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees); Blueprint Medicines – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Consultant(Honoraria); Novartis – Investigator(Grants/Research Funding); Protagonist Therapeutics – Consultant(Fees); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights);
Beth McLellan, MD, FAAD
Bristol Myers Squibb – Investigator(Grants/Research Funding); Hoth Therapeutics – Investigator(Grants/Research Funding); Kintara Therapeutics, Inc. – Investigator(Grants/Research Funding); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Paula's Choice – Advisory Board(Honoraria); Paxman – Investigator(Equipment); Pfizer Inc. – Other(Grants/Research Funding); RBC Consultants – Advisory Board(Honoraria); Spruce – Advisory Board(Stock Options); UpToDate – Other(Fees);
Miriam Keltz Pomeranz, MD, FAAD
Incyte Corporation – Consultant(No Compensation Received); Procter & Gamble Company – Advisory Board(Fees); UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights);